Wellthy Therapeutics, a Mumbai-based startup has raised $4million (around Rs 30 crore) from Saama Capital, as part of its Pre-Series Around, for a 16% stake in the company.
As per a report, Suresh Shanmugham who is Managing partner at Saama Capital, will join Wellthy’s board.
“The funding will allow us to invest further into improving patient outcomes and generate further real-world evidence, while expanding our therapeutic portfolio, geographic and stakeholder reach,” Abhishek Shah, CEOand Co-founder of Wellthy Therapeutics was quoted as saying by ET.
“Wellthy Therapeutics is bringing technology-enabled affordable digital therapeutics to make patient outcomes more accessible,” said Suresh Shanmugham, Managing Partner at Saama Capital.
The company had earlier raised a seed round of Rs 13.5 crore led by GrowX Ventures, Beenext Ventures and other HNIs. In 2019, the company had picked up Rs 10.5 crore from drug maker Cipla.